TrialCancer research and treatment2015

Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-Line Treatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Trial.

Dae Ho Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.